Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population.
Mousavi Khorshidi MS, Seeleuthner Y, Chavoshzadeh Z, Behfar M, Hamidieh AA, Alimadadi H, Sherkat R, Momen T, Behniafard N, Eskandarzadeh S, Mansouri M, Behnam M, Mahdavi M, Heydarazad Zadeh M, Shokri M, Alizadeh F, Movahedi M, Momenilandi M, Keramatipour M, Casanova JL, Cobat A, Abel L, Shahrooei M, Parvaneh N.
Mousavi Khorshidi MS, et al. Among authors: casanova jl.
J Clin Immunol. 2023 Nov;43(8):1941-1952. doi: 10.1007/s10875-023-01562-z. Epub 2023 Aug 16.
J Clin Immunol. 2023.
PMID: 37584719